Mahmoudian Massoud, Ebrahimi Soltan Ahmed, Kiani Zahra
Razi Institute for Drug Research, Department of Pharmacology, Iran University of Medical Sciences, Tehran, Iran.
J Res Med Sci. 2009 Jul;14(4):205-9.
Patients with Alzheimer's disease (AD) reportedly exhibit hypersensitivity to much diluted tropicamide solution (0.005%), a M4 muscarinic receptor antagonist. Therefore intraocular application of 0.005% tropicamide may be useful for screening dementia. The aim of this study was to simplify the pupil response test by using a new image analyzing system, which consists of a cheap, simple, and easy to use web-camera and a computer.
Intraocular tropicamide of 0.005% concentration was administered in 3 groups: Alzheimer's disease patients (n = 8, average age = 76 ± 5), non-Alzheimer's disease elderly (n = 6, average age = 65 ± 7), and young subjects (n = 8, average age = 28 ± 5). Every 5 minutes for 60 minutes, image of the eye's shape were taken, and the diameter of the pupils was measured.
The results showed that differences in pupil dilation rate between Alzheimer's disease and non-Alzheimer's disease subjects were statistically significant. ROC analysis showed that after 35 minutes the sensitivity and specificity of the test were 100%.
Based on our results, we concluded that this recording system might be an appropriate and reliable tool for pupil response diagnosis test of Alzheimer's disease.
据报道,阿尔茨海默病(AD)患者对稀释度很高的托吡卡胺溶液(0.005%)表现出超敏反应,托吡卡胺是一种M4毒蕈碱受体拮抗剂。因此,眼内应用0.005%托吡卡胺可能有助于痴呆症的筛查。本研究的目的是通过使用一种新的图像分析系统简化瞳孔反应测试,该系统由一台廉价、简单且易于使用的网络摄像头和一台计算机组成。
对3组受试者眼内给予浓度为0.005%的托吡卡胺:阿尔茨海默病患者(n = 8,平均年龄 = 76 ± 5岁)、非阿尔茨海默病老年人(n = 6,平均年龄 = 65 ± 7岁)和年轻受试者(n = 8,平均年龄 = 28 ± 5岁)。在60分钟内每隔5分钟拍摄一次眼睛形状的图像,并测量瞳孔直径。
结果显示,阿尔茨海默病患者与非阿尔茨海默病受试者之间的瞳孔扩张率差异具有统计学意义。受试者工作特征(ROC)分析表明,35分钟后该测试的敏感性和特异性均为100%。
基于我们的研究结果,我们得出结论,该记录系统可能是阿尔茨海默病瞳孔反应诊断测试的一种合适且可靠的工具。